The Association of Urinary Sclerostin and Renal Magnesium Handling in Type 2 Diabetic Patients with Chronic Kidney Disease

被引:3
|
作者
Wu, Ching-Fang [1 ,2 ]
Liou, Hung-Hsiang [3 ,4 ]
Kuo, Chin-Chi [5 ,6 ]
Tsai, Ming-Hsien [7 ]
Chang, Min-Yu [1 ,4 ]
Lee, Yi-Che [1 ,8 ]
Lin, Tsun-Mei [9 ,10 ]
Hung, Shih-Yuan [1 ,4 ]
机构
[1] I Shou Univ, Coll Med, Sch Med, Kaohsiung, Taiwan
[2] E Da Canc Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan
[3] Hsin Jen Hosp, Dept Internal Med, Div Nephrol, New Taipei, Taiwan
[4] E Da Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan
[5] China Med Univ, China Med Univ Hosp, Big Data Ctr, Taichung, Taiwan
[6] China Med Univ Hosp, Dept Internal Med, Div Nephrol, Taichung, Taiwan
[7] Shin Kong Wu Ho Su Mem Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan
[8] E Da Dachang Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan
[9] I Shou Univ, Dept Med Lab Sci, Kaohsiung, Taiwan
[10] E Da Hosp, Dept Med Res, Kaohsiung, Taiwan
关键词
Chronic kidney disease; Sclerostin; Fractional excretion of calcium; Fractional excretion of magnesium; Type 2 diabetes mellitus; METABOLISM; CALCIUM;
D O I
10.1159/000516844
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Introduction: Sclerostin could enhance renal excretion of calcium (Ca) and phosphate (P). The association between sclerostin and magnesium (Mg) has not yet discovered. In patients with type 2 diabetes mellitus (T2DM) or chronic kidney disease (CKD), higher serum sclerostin and altered renal excretion of Ca, P, and Mg were detected. Therefore, we tried to evaluate if there was any association between sclerostin and fractional excretion of Ca, P, and Mg (FeCa, FeP, and FeMg) in T2DM with CKD. Methods: In this prospective cohort study, 43 T2DM patients without CKD or with CKD stage 1-5 were enrolled. Values of parameters, including serum and urine sclerostin, were collected at baseline and 6 months later. For baseline data, the Mann-Whitney U test, chi(2) test, or Spearman's correlation were used. For multivariate repeated measurement analysis, generalized estimating equation (GEE) model was utilized. Results: Patients with lower estimated glomerular filtration rate had higher serum sclerostin, FeP, FeMg, and lower FeCa. By correlation analysis, serum sclerostin was negatively associated with FeCa (p = 0.02) and positively associated with FeP (p = 0.002). The urine sclerostin to creatinine ratio (Uscl/Ucre) was positively correlated with FeP (p = 0.007) and FeMg (p = 0.005). After multivariate analyses by GEE model, serum sclerostin was still inversely associated with FeCa, while Uscl/Ucre was significantly associated with FeMg. On the other hand, FeP lost its associations with serum sclerostin or Uscl/Ucre. Conclusion: In our study population of T2DM patients with or without CKD, the inverse correlation between serum sclerostin and FeCa could not be explained by the calciuric effect of sclerostin. In addition, a newly discovered positive association between urinary sclerostin and FeMg indicated a possible role of urinary sclerostin in regulating renal Mg handling especially over distal convoluted tubules.
引用
收藏
页码:514 / 522
页数:9
相关论文
共 50 条
  • [31] Increased serum concentrations of inflammatory cytokines in type 2 diabetic patients with chronic kidney disease
    Konenkov, V. I.
    Klimontov, V. V.
    Myakina, N. E.
    Tyan, N. V.
    Fazullina, O. N.
    Romanov, V. V.
    TERAPEVTICHESKII ARKHIV, 2015, 87 (06) : 45 - 49
  • [32] Phosphorus as an early marker of morbidity and mortality in type 2 chronic kidney disease diabetic patients
    Silva, Ana Paula
    Fragoso, Andre
    Pinho, Ana
    Tavares, Nelson
    Camacho, Ana
    Faisca, Marilia
    Neves, Pedro Leao
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2013, 27 (04) : 328 - 332
  • [33] Is serum sclerostin a marker of atherosclerosis in patients with chronic kidney disease-mineral and bone disorder?
    Figurek, Andreja
    Spasovski, Goce
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2018, 50 (10) : 1863 - 1870
  • [34] Study of serum sclerostin levels and its role in vascular calcification in patients with chronic kidney disease
    Ahmed R. Elarbagy
    Yassein S. Yassein
    Mahmoud M. Emara
    Ahmed A. Sonbol
    Khaled M. A. Elzorkany
    Amera A. Sharaf El Deen
    The Egyptian Journal of Internal Medicine, 2019, 31 (4) : 813 - 821
  • [35] FREQUENCY OF URINARY TRACT INFECTION AND RENAL OUTCOMES IN ADVANCED CHRONIC KIDNEY DISEASE PATIENTS
    Ya-Chun, Huang
    Wan-Ting, Chen
    You-Hsien, Lin Hugo
    I-Ching, Kuo
    Sheng-Wen, Niu
    Shang-Jyh, Hwang
    Hung-Chun, Chen
    Chi-Chih, Hung
    NEPHROLOGY, 2014, 19 : 166 - 166
  • [36] Diabetic kidney disease versus non-diabetic kidney disease in type 2 diabetic patients on dialysis: An observational cohort
    Delautre, Arnaud
    Hannedouche, Thierry
    Couchoud, Cecile
    Guiserix, Jose
    Cerasuolo, Damiano
    Chantrel, Francois
    Martzloff, Jonas
    Keller, Nicolas
    Krummel, Thierry
    ENDOCRINOLOGY DIABETES & METABOLISM, 2022, 5 (04)
  • [37] Raman spectroscopy of urinary extracellular vesicles to stratify patients with chronic kidney disease in type 2 diabetes
    Kaminska, Agnieszka
    Roman, Maciej
    Wrobel, Andrzej
    Gala-Bladzinska, Agnieszka
    Malecki, Maciej T.
    Paluszkiewicz, Czeslawa
    Stepien, Ewa L.
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2022, 39
  • [38] 24-h Urinary Calcium Excretion and Renal Outcomes in Hospitalized Patients with and without Chronic Kidney Disease
    Guo, Xinru
    Wang, Wanling
    Ma, Yangyang
    Liang, Yanjun
    Zhou, Yena
    Cai, Guangyan
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (14)
  • [39] A Retrospective Observational Study of Insulin Glargine in Type 2 Diabetic Patients with Advanced Chronic Kidney Disease
    Majumder, Anirban
    RoyChaudhuri, Soumyabrata
    Sanyal, Debmalya
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (11)
  • [40] Urinary angiotensinogen levels reflect the severity of renal histopathology in patients with chronic kidney disease
    Kim, S. M.
    Jang, H. R.
    Lee, Y-J
    Lee, J. E.
    Huh, W. S.
    Kim, D. J.
    Oh, H. Y.
    Kim, Y-G
    CLINICAL NEPHROLOGY, 2011, 76 (02) : 117 - 123